Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 21 -30 of 101 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


21.		Phase III Comparison of Electron Beam Radiotherapy plus ADR/CTX/VP-16/VCR vs Topical Therapy for Stage I/II/III/IV Mycosis Fungoides and Sezary Syndrome

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified				NCI				NCI-79-C-70 NCI-NMOB-816, NCI-T83-1451N, NCI-N81-900, N81-0900

Last Modified: 4/1/1997


22.		Phase III ProMACE (PRED/MTX/ADR/CTX/VP-16) with MOPP (NM/VCR/PCB/PRED) vs CytaBOM (ARA-C/BLEO/VCR/MTX) for Stage II/III/IV Aggressive Diffuse Lymphoma (Summary Last Modified 04/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				15 and over				NCI				NCI-81-C-166A NCI-MB-161, NCI-T84-0248N, T84-0248

Last Modified: 9/7/2007


23.		Phase III ProMACE (PRED/MTX/ADR/CTX/VP-16) and MOPP (NM/VCR/PCB/PRED) plus Radiotherapy for Stage I Diffuse Aggressive Lymphomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 and over				NCI				BRMP-8914 NCI-81-C-178, NCI-MB-166, NCI-T83-0977N, T83-0977

Last Modified: 6/30/2006


24.		Phase III Alternating MOPP (NM/VCR/PCB/PRED) and CABS (SZC/CCNU/ADR/BLEO) vs MOPP Alone for Stage III/IV Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				15 and over								NCI-78-C-118 UMCC-7808, NCI-MB-114, NCI-T83-0983, T83-0983


25.		Phase III Radiation plus BCVPP (BCNU/CTX/VBL/PCB/PRED) vs BCVPP Alone vs MOPP-ABVD (NM/VCR/PCB/PRED-ADR/BLEO/VBL/DTIC) for Stage III/IV Hodgkin's Disease (Summary last modified 06/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				16 and over				NCI				EST-1481 EST-1481


26.		Phase III ECHO (VP-16/CTX/ADR/VCR), NM/PCB/HDMTX/CF, ABMT, Protected Environment, Adjuvant Surgery, and Radiotherapy for Limited and Extensive Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				under 70								MDA-DT-8065 NCI-D81-043-347

Last Modified: 7/20/2007


27.		Phase III Regional Limb Perfusion with L-PAM or L-PAM/NM/ACT-D plus Excision vs Excision Alone for Stage I/II/III Invasive Melanoma of the Extremities

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				under 65								NCI-D80-065-383 ULCC-HSC-7180

Last Modified: 6/14/2007


28.		Phase III Randomized Study of Chemotherapy with MOP-BAP (NM/VCR/PCB/ADR/BLEO/PRED) Followed by No Further Treatment or Involved Field Radiotherapy in Patients with Stage III/IV Hodgkin's Disease --- MOPP#6

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				15 and over				NCI				SWOG-7808 SWOG-7808


29.		Phase III Combination Topical Chemotherapy, Systemic Chemotherapy, and Whole-Body Electron Beam Therapy for Mycosis Fungoides and Sezary Syndrome

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over								MFCG-1


30.		Phase III Combination Chemotherapy with MVVPP (NM/VCR/VBL/PRED/PCB) vs MOPP (NM/VCR/PRED/PCB) Followed by Low-Dose Radiotherapy in Patients with Stage III/IV Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified				NCI				YALE-HIC-1636 NCI-T83-1405D

Select All on One Page


					< Previous 1 2 3 4 5 6 Next >

| | | | | | | |

A Service of the National Cancer Institute